BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26016513)

  • 1. Tissue Factor and Atherothrombosis.
    Tatsumi K; Mackman N
    J Atheroscler Thromb; 2015; 22(6):543-9. PubMed ID: 26016513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque.
    Owens AP; Mackman N
    Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S30-3. PubMed ID: 22444158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tissue factor in atherothrombosis.
    Owens AP; Mackman N
    Curr Atheroscler Rep; 2012 Oct; 14(5):394-401. PubMed ID: 22886473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor and atherothrombosis.
    Saha D; S S; Sergeeva EG; Ionova ZI; Gorbach AV
    Curr Pharm Des; 2015; 21(9):1152-7. PubMed ID: 25312727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor in atherosclerosis and atherothrombosis.
    Grover SP; Mackman N
    Atherosclerosis; 2020 Aug; 307():80-86. PubMed ID: 32674807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of tissue factor induced atherothrombosis in apolipoprotein E-/- mice via both enhanced plaque thrombogenicity and plaque instability.
    Liu X; Ma J; Ma L; Liu F; Zhang C; Zhang Y; Ni M
    J Mol Cell Cardiol; 2019 Feb; 127():1-10. PubMed ID: 30500376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.
    Grover SP; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):709-725. PubMed ID: 29437578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Tissue Factor in the Coagulation Network.
    Cimmino G; Ciccarelli G; Golino P
    Semin Thromb Hemost; 2015 Oct; 41(7):708-17. PubMed ID: 26408920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression.
    Egorina EM; Sovershaev MA; Bogdanov VY; Sovershaev TA; Fallon JT; Seredkina N; Østerud B; Hansen JB
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):642-50. PubMed ID: 21897206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity.
    Matsuura Y; Yamashita A; Iwakiri T; Sugita C; Okuyama N; Kitamura K; Asada Y
    Thromb Haemost; 2015 Jul; 114(1):158-72. PubMed ID: 25833755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective and pathological roles of tissue factor in the heart.
    Bode MF; Mackman N
    Hamostaseologie; 2015; 35(1):37-46. PubMed ID: 25434707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis.
    Hutter R; Valdiviezo C; Sauter BV; Savontaus M; Chereshnev I; Carrick FE; Bauriedel G; Lüderitz B; Fallon JT; Fuster V; Badimon JJ
    Circulation; 2004 Apr; 109(16):2001-8. PubMed ID: 15078795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factor.
    Sovershaev MA; Egorina EM; Bogdanov VY; Seredkina N; Fallon JT; Valkov AY; Østerud B; Hansen JB
    Thromb Res; 2010 Oct; 126(4):306-10. PubMed ID: 20656331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.
    Liu ML; Reilly MP; Casasanto P; McKenzie SE; Williams KJ
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):430-5. PubMed ID: 17158353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.
    Jiang P; Xue D; Zhang Y; Ye L; Liu Y; Makale M; Kesari S; Edgington TS; Liu C
    Thromb Res; 2014 Apr; 133(4):657-66. PubMed ID: 24485401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of tissue factor in cardiovascular disease.
    Jude B; Zawadzki C; Susen S; Corseaux D
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis as a determinant of atherothrombosis.
    Tedgui A; Mallat Z
    Thromb Haemost; 2001 Jul; 86(1):420-6. PubMed ID: 11487033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.